DOC News Track the topics, authors and articles important to you
HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
 QUICK SEARCH:   [advanced]


     


DOC News    January 1, 2008
Volume 5 Number 1 p. 6
© 2008 American Diabetes Association

Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Law, B. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Law, B. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Heart Failure Patients Discharged With Subpar BP Control

Bridget Murray Law

Minority patients fare worst

Roughly a third of heart failure patients are discharged from hospitals with blood pressure (BP) readings >140/90 mmHg—levels higher than those recommended by the American Heart Association's (AHA's) Get With the Guidelines Heart Failure quality-improvement program.

Black patients demonstrated the poorest blood pressure control, with just 63% achieving optimal levels, according to analyses of records from 19,206 heart failure patients with diagnosed hypertension. By comparison, 76% of white men and 71% of white women attain the recommended levels at discharge.

In addition, roughly 66% of patients are discharged on three or more hypertension drugs. "That number should be 100% for these patients," asserts lead researcher Daniel T. Lackland, DPH, a professor in the department of biometry and epidemiology at Medical University of South Carolina in Charleston.

The data come from 195 hospitals that pooled patient data on the Internet through the Get With the Guidelines program. On presenting the data at AHA's 2007 Scientific Sessions, held November 4–7 in Orlando, Fla., Lackland noted below-desirable treatment with hypertension drugs in this high-risk population: Only 62% were on diuretics, 65% were on angiotensin-converting enzyme (ACE) inhibitors, and just 19% were on angiotensin II receptor blockers (ARBs).

"These patients are not getting to goal," says Lackland. "Barely 50% have pressures down to 130/80. All of them should be on an ACE or an ARB. We've got to get more aggressive with treatment."

His top recommendation: Greater collaboration between cardiologists and primary care physicians to add drugs or increase dosages until patients achieve optimal blood pressure control.

Footnotes

FYI

More information on the American Heart Association's Get With the Guidelines cardiac care quality improvement program is available at www.americanheart.org/presenter.jhtml?identifier=1165.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Law, B. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Law, B. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
DOC News Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum